BioCryst Pharmaceuticals
BCRX
#4357
Rank
A$3.07 B
Marketcap
$14.85
Share price
0.91%
Change (1 day)
66.61%
Change (1 year)

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2024 (TTM): A$0.61 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$0.64 Billion. In 2023 the company made a revenue of A$0.48 Billion an increase over the revenue in the year 2022 that were of A$0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2024

20002005201020152020$0.2B$0.4B$0.6B$0.8B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) A$0.61 B25.82%
2023 A$0.48 B22.23%
2022 A$0.39 B83.58%
2021 A$0.21 B835.87%
2020 A$23.16 M-66.79%
2019 A$69.75 M137.92%
2018 A$29.31 M-9.13%
2017 A$32.26 M-11.76%
2016 A$36.55 M-44.81%
2015 A$66.24 M298.39%
2014 A$16.62 M-14.42%
2013 A$19.42 M-23.21%
2012 A$25.3 M32.07%
2011 A$19.15 M-68.81%
2010 A$61.41 M-26.04%
2009 A$83.03 M3.57%
2008 A$80.17 M-1.61%
2007 A$81.48 M934.18%
2006 A$7.87 M3696.08%
2005 A$0.2 M1704.46%
2004 A$0.01 M-99.48%
2003 A$2.19 M-30.21%
2002 A$3.14 M-85.59%
2001 A$21.86 M972.64%
2000 A$2.03 M-50.27%
1999 A$4.09 M-61.98%
1998 A$10.77 M485.21%
1997 A$1.84 M-43.72%
1996 A$3.27 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$0.97 B 50.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.57 B 297.58%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.32 B 105.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.34 B 6,758.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.63 M-97.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$63.07 B 9,656.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$1.71 B 165.21%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA